ILMN logo

Illumina (ILMN)

Profile

Full Name

Illumina, Inc.

Ticker Symbol

ILMN

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

July 28, 2000

Indexes

Not included

Website

http://www.illumina.com

Employees

8970

Key Details

Price

$74.78(+4.94%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.37B(-2.93% YoY)

Annual EPS

-$7.69(-4.77% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$74.78
ILMN price is $74.78

30-Day Relative Volume

1.17
ILMN 30-day relative volume is 1.17

Price Performance

Price Most recent change

+4.94%
ILMN price was up +4.94% on Apr 11, 2025

Price YTD change

-44.04%
ILMN price is down -44.04% since January 1st

Price 1-year change

-41.18%
ILMN price is down -41.18% year-on-year

Price 3-year change

-78.12%
ILMN price is down -78.12% over the past 3 years

Price Range

Price All-time high

$555.77
ILMN price is currently -86.54% below its historical high of $555.77

Price 3-year low

$68.70
ILMN price is currently +8.85% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.85B
ILMN market capitalization is $11.85 billion

Market cap 3-year change

-77.92%
ILMN market capitalization is down -77.92% over the past 3 years

Market cap All-time high

$77.73B
ILMN market capitalization is currently -84.76% below its historical high of $77.73 billion

Market cap sector rank

93.92%
ILMN market capitalization is higher than 93.92% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.38%
ILMN shares outstanding is down -0.38% year-on-year

Shares Outstanding 3-Year Change

+0.89%
ILMN shares outstanding is up +0.89% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.98
ILMN beta is 0.98

200-day SMA

$122.49
ILMN price is currently -38.95% below its 200-day simple moving average

50-day SMA

$91.41
ILMN price is currently -18.19% below its 50-day simple moving average

RSI

38.46
ILMN 14-day relative strength index is 38.46

Volume

1.17
ILMN 30-day relative volume is 1.17

ATR

$4.70
ILMN average true range is $4.70

10-day Historical Volatility

80.64%
ILMN 10-day historical volatility is 80.64%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.37B
ILMN annual revenue is $4.37 billion

Revenue Analysts estimate

$4.30B
ILMN annual revenue is currently +1.67% higher than the consensus analysts' forecast

Revenue 1-year change

-2.93%
ILMN annual revenue is down -2.93% year-on-year

Revenue Sector rank

91.27%
ILMN annual revenue is higher than 91.27% of companies in Healthcare sector

EPS

EPS

-$7.69
ILMN annual earnings per share is -$7.69

EPS Analysts estimate

$4.46
ILMN annual earnings per share is currently -272.26% lower than the consensus analysts' forecast

EPS 1-year change

-4.77%
ILMN annual earnings per share is down -4.77% year-on-year

EPS Sector rank

14.04%
ILMN annual earnings per share is higher than 14.04% of companies in Healthcare sector

Profit

Gross profit

$2.86B
ILMN annual gross profit is $2.86 billion

Gross margin

65.44%
ILMN annual gross profit margin is 65.44%

Operating profit

$600.00M
ILMN annual operating income is $600.00 million

Operating margin

13.72%
ILMN annual operating profit margin is 13.72%

Net income

-$1.22B
ILMN annual net profit is -$1.22 billion

Net margin

-27.97%
ILMN annual net profit margin is -27.97%

Expenses

Total expenses

$3.77B
ILMN annual total expenses is $3.77 billion

Operating expenses

$2.26B
ILMN annual total operating expenses is $2.26 billion

Cost of goods sold

$1.51B
ILMN annual cost of goods sold is $1.51 billion

Selling, general & administrative expenses

$1.09B
ILMN annual SGA is $1.09 billion

Depreciation and amortization

$354.00M
ILMN annual depreciation & amortization is $354.00 million

Interest expense

$100.00M
ILMN annual interest expense is $100.00 million

Income tax

$44.00M
ILMN annual income tax is $44.00 million

EBIT & EBITDA

EBIT

$600.00M
ILMN annual earnings before interest & taxes is $600.00 million

EBITDA

$600.00M
ILMN annual EBITDA is $600.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$6.30B
ILMN annual total assets is $6.30 billion

Non current assets

$3.56B
ILMN annual long term assets is $3.56 billion

Current assets

$2.75B
ILMN annual total current assets is $2.75 billion

Cash and cash equivalents

$1.13B
ILMN annual cash & cash equivalents is $1.13 billion

Accounts receivable

$735.00M
ILMN annual accounts receivable is $735.00 million

Inventory

$547.00M
ILMN annual inventory is $547.00 million

Liabilities

Total liabilities

$3.93B
ILMN annual total liabilities is $3.93 billion

Long term liabilities

$2.38B
ILMN annual total long term liabilities is $2.38 billion

Current liabilities

$1.55B
ILMN annual total current liabilities is $1.55 billion

Accounts payable

$221.00M
ILMN annual accounts payable is $221.00 million

Debt

Total debt

$2.62B
ILMN annual total debt is $2.62 billion

Total debt 1-year change

+15.92%
ILMN annual total debt is up +15.92% year-on-year

Long term debt

$2.04B
ILMN annual long term debt is $2.04 billion

Short term debt

$578.00M
ILMN annual short term debt is $578.00 million

Equity & Capital

Shareholders equity

$2.37B
ILMN annual stockholders equity is $2.37 billion

Book value

$2.37B
ILMN annual book value is $2.37 billion

Retained earnings

-$1.24B
ILMN annual retained earnings is -$1.24 billion

Working capital

$1.20B
ILMN annual working capital is $1.20 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$837.00M
ILMN annual cash flow from operations is $837.00 million

Cash from operations 1-year change

+75.1%
ILMN annual cash flow from operations is up +75.1% year-on-year

Cash from investing

-$178.00M
ILMN annual cash flow from investing activities is -$178.00 million

Cash from investing 1-year change

+22.94%
ILMN annual cash flow from investing activities is up +22.94% year-on-year

Cash from financing

-$570.00M
ILMN annual cash flow from financing activities is -$570.00 million

Cash from financing 1-year change

+52.89%
ILMN annual cash flow from financing activities is up +52.89% year-on-year

CAPEX

CAPEX

$128.00M
ILMN annual capital expenditures is $128.00 million

CAPEX 1-year change

-34.36%
ILMN annual capital expenditures is down -34.36% year-on-year

Free Cash Flow

Free cash flow

$837.00M
ILMN annual free cash flow is $837.00 million

Free cash flow 1-year change

+196.81%
ILMN annual free cash flow is up +196.81% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

65.44%
ILMN annual gross profit margin is 65.44%

Operating margin

13.72%
ILMN annual operating profit margin is 13.72%

Net margin

-27.97%
ILMN annual net profit margin is -27.97%

ROA & ROE

ROA

-14.90%
ILMN annual return on assets is -14.90%

ROE

-30.13%
ILMN annual return on equity is -30.13%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ILMN price to earnings ratio value is unknown

PE ratio Sector rank

-
ILMN price to earnings ratio is unknown

PB Ratio

PB ratio

4.99
ILMN price to book ratio is 4.99

PB ratio Sector rank

83.63%
ILMN price to book ratio is higher than 83.63% of companies in Healthcare sector

PS Ratio

PS ratio

2.71
ILMN price to sales ratio is 2.71

PS ratio Sector rank

50.13%
ILMN price to sales ratio is higher than 50.13% of companies in Healthcare sector

Enterprise value

Enterprise value

$13.34B
ILMN enterprise value is $13.34 billion

Enterprise value Sector rank

93.48%
ILMN enterprise value is higher than 93.48% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-16.37
ILMN EV/EBITDA is -16.37

EV/EBITDA Sector rank

7.38%
ILMN EV/EBITDA is higher than 7.38% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.78
ILMN annual current ratio is 1.78

Quick ratio

1.42
ILMN annual quick ratio is 1.42

Leverage

Debt to equity

0.84
ILMN annual debt to equity ratio is 0.84

Interest coverage ratio

6.00
ILMN annual interest coverage ratio is 6.00

Risk & Stability

Piotroski F-Score

6
ILMN piotroski f-score is 6

Altman Z-Score

2.77
ILMN altman z-score is 2.77

Analyst ratings

Recent major analysts updates

Apr 10, 25 Barclays
Underweight
Apr 8, 25 RBC Capital
Outperform
Apr 7, 25 Citigroup
Neutral
Mar 12, 25 RBC Capital
Outperform
Mar 11, 25 Stephens & Co.
Overweight
Mar 11, 25 Canaccord Genuity
Hold
Mar 5, 25 Baird
Neutral
Mar 4, 25 Citigroup
Neutral
Feb 11, 25 Morgan Stanley
Equal-Weight
Feb 10, 25 Piper Sandler
Overweight

Institutional Ownership

Similar stocks

THC logo
Tenet Healthcare (THC)
GMAB logo
Genmab A/S (GMAB)
ICLR logo
ICON Public Limited (ICLR)
ALGN logo
Align Technology (ALGN)
SOLV logo
Solventum (SOLV)
UHS logo
Universal Health Services (UHS)
RVTY logo
Revvity (RVTY)
SNN logo
Smith & Nephew (SNN)
INSM logo
Insmed Incorporated (INSM)
  • What is the ticker symbol for Illumina?
  • Does Illumina pay dividends?
  • What sector is Illumina in?
  • What industry is Illumina in?
  • What country is Illumina based in?
  • When did Illumina go public?
  • Is Illumina in the S&P 500?
  • Is Illumina in the NASDAQ 100?
  • Is Illumina in the Dow Jones?
  • When was Illumina's last earnings report?
  • When does Illumina report earnings?
  • Should I buy Illumina stock now?

What is the ticker symbol for Illumina?

The ticker symbol for Illumina is NASDAQ:ILMN

Does Illumina pay dividends?

No, Illumina does not pay dividends

What sector is Illumina in?

Illumina is in the Healthcare sector

What industry is Illumina in?

Illumina is in the Diagnostics & Research industry

What country is Illumina based in?

Illumina is headquartered in United States

When did Illumina go public?

Illumina's initial public offering (IPO) was on July 28, 2000

Is Illumina in the S&P 500?

No, Illumina is not included in the S&P 500 index

Is Illumina in the NASDAQ 100?

No, Illumina is not included in the NASDAQ 100 index

Is Illumina in the Dow Jones?

No, Illumina is not included in the Dow Jones index

When was Illumina's last earnings report?

Illumina's most recent earnings report was on Feb 6, 2025

When does Illumina report earnings?

The next expected earnings date for Illumina is May 8, 2025

Should I buy Illumina stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page